CLOPENTHIXOL

Approval Year

PubMed

Title	Date	PubMed
Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.	2014-05-15	24582773
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate.	2014-03	23771405
Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry.	2012-09	22718540
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.	2012-04-18	22513898
Severe laryngeal dystonia in a patient receiving zuclopenthixol "Acuphase" and fluoxetine.	2010-04	20175668
Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole.	2009-11-13	19766686
Fatal exertional heat stroke in a patient receiving zuclopenthixol, quetiapine and benztropine.	2007	18025545
[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].	2006-06	16856516
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.	2005-07	15965227
Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats.	2004-08	15497819
Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms.	2003-07	12957216
Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.	2001-07	11549212
Clozapine and weight gain.	2001-05	11329412
Effect of some psychotropic drugs and a barbiturate on mycoplasmas.	2000-04	10773494
[acute dystonias in combined abuse of cocaine and neuroleptics].	1994-11-26	7990989
Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.	1991-12	1822319
Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology.	1989-05	2732745
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.	1989	2568639
Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.	1987-07	3615572
Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime.	1987-01	3651662
The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria.	1986-12	3105243
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.	1967	4383787

Patents

Substance Class	Mixture Created by `admin` on `Mon Mar 31 20:12:16 GMT 2025` Edited by `admin` on `Mon Mar 31 20:12:16 GMT 2025`
Record UNII	0A432D932A
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SORDINOL

Preferred Name

English

CLOPENTHIXOL

Official Name

English

NSC-64087

Code

English

CLOPENTHIXOL [MI]

Common Name

English

AY-62021

Code

English

Clopenthixol [WHO-DD]

Common Name

English

1-PIPERAZINEETHANOL, 4-(3-(2-CHLORO-9H-THIOXANTHEN-9-YLIDENE)PROPYL)-

Common Name

English

clopenthixol [INN]

Common Name

English

4-[3-(2-Chlorothioxanthen-9-ylidene)propyl]-1-piperazineethanol

Common Name

English

CLOPENTHIXOL [USAN]

Common Name

English

N-746

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C66883